scispace - formally typeset
B

Bernd W. Scheithauer

Researcher at Mayo Clinic

Publications -  729
Citations -  58507

Bernd W. Scheithauer is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Adenoma & Pituitary adenoma. The author has an hindex of 119, co-authored 729 publications receiving 55985 citations. Previous affiliations of Bernd W. Scheithauer include University of North Dakota & University of Michigan.

Papers
More filters
Journal ArticleDOI

Meningioma grading: an analysis of histologic parameters.

TL;DR: Brain invasion and an increased mitotic index are the most powerful histologic factors prognostic for recurrence in meningiomas and an objective definition for atypicalMeningioma is proposed based on data.
Journal ArticleDOI

PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme.

TL;DR: PTEN mutation and EGFR amplification are important prognostic factors in patients with anaplastic astrocytoma and in older patients with glioblastoma multiforme, respectively.
Journal ArticleDOI

Thymoma. A clinicopathologic review.

TL;DR: The clinical and pathologic features of 283 patients with thymoma treated at the Mayo Clinic were examined and poor prognostic factors included presence of tumor‐related symptoms, large tumor size, local invasion or metastasis in initial operation, and predominantly epithelial histologic features.
Journal ArticleDOI

A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases.

TL;DR: The profound heterogeneity in extent and topography of OG destruction in active demyelinating lesions suggests that in subsets of multiple sclerosis patients, myelin, mature OGs and possibly OG progenitors are differentially affected.
Journal ArticleDOI

Temporal lobe seizures: lateralization with MR volume measurements of the hippocampal formation.

TL;DR: A retrospective magnetic resonance (MR) imaging study was performed in 41 right-handed patients with presumed mesial sclerosis who underwent surgery for medically intractable, complex partial seizures of temporal lobe origin, finding DHF measurements to be 76% sensitive and 100% specific for correct seizure lateralization.